Related content

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study

By Delva R.   Pienkowski T.   Tubiana N.   Vanhoefer U.   Longerey B.   Douville I.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 703-709

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

By Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1773-1780

Elsevier

Access to resources Recommend Favorite

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

By Venturini M.   Bighin C.   Monfardini S.   Cappuzzo F.   Olmeo N.   Durando A.   Puglisi F.   Nicoletto O.   Lambiase A.   Mastro L.  

Breast Cancer Research and Treatment, Vol. 95, Iss. 1, 2006-01 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Data and Pharmacokinetics of a Docetaxel-vinorelbine Combination in Anthracycline Resistant/Relapsed Metastatic Breast Cancer

By Airoldi Mario   Cattel Luigi   Pedani Fulvia   Marchionatti Sara   Tagini Valentina   Bumma Cesare   Recalenda Valeria  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 186-194

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer

By Mariani G.  

Breast Cancer Research and Treatment, Vol. 70, Iss. 3, 2001-12 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite